Eagle Pharmaceuticals, Inc. (EGRX)
1.025
+0.12
(+13.89%)
USD |
OTCM |
Sep 25, 16:00
Eagle Pharmaceuticals Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 0.0533 |
| September 24, 2026 | 0.0468 |
| September 23, 2026 | 0.0468 |
| September 22, 2026 | 0.0468 |
| September 21, 2026 | 0.0468 |
| September 18, 2026 | 0.0668 |
| September 17, 2026 | 0.0668 |
| September 16, 2026 | 0.0668 |
| September 15, 2026 | 0.0668 |
| September 14, 2026 | 0.0668 |
| September 11, 2026 | 0.0084 |
| September 10, 2026 | 0.0392 |
| September 09, 2026 | 0.039 |
| September 08, 2026 | 0.039 |
| September 04, 2026 | 0.039 |
| September 03, 2026 | 0.039 |
| September 02, 2026 | 0.0475 |
| September 01, 2026 | 0.0481 |
| August 31, 2026 | 0.0481 |
| August 28, 2026 | 0.0481 |
| August 27, 2026 | 0.0481 |
| August 26, 2026 | 0.0356 |
| August 25, 2026 | 0.0275 |
| August 24, 2026 | 0.0275 |
| August 21, 2026 | 0.0275 |
| Date | Value |
|---|---|
| August 20, 2026 | 0.0275 |
| August 19, 2026 | 0.0309 |
| August 18, 2026 | 0.0309 |
| August 17, 2026 | 0.0309 |
| August 14, 2026 | 0.0309 |
| August 13, 2026 | 0.0309 |
| August 12, 2026 | 0.0309 |
| August 11, 2026 | 0.0055 |
| August 10, 2026 | 0.0036 |
| August 07, 2026 | 0.0026 |
| August 06, 2026 | 0.0026 |
| August 05, 2026 | 0.0026 |
| August 04, 2026 | 0.0192 |
| August 03, 2026 | 0.0192 |
| July 31, 2026 | 0.0192 |
| July 30, 2026 | 0.0192 |
| July 29, 2026 | 0.0192 |
| July 28, 2026 | 0.0192 |
| July 27, 2026 | 0.0192 |
| July 24, 2026 | 0.0192 |
| July 23, 2026 | 0.0192 |
| July 22, 2026 | 0.0229 |
| July 21, 2026 | 0.0229 |
| July 20, 2026 | 0.0309 |
| July 17, 2026 | 0.0309 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.665 |
| Alnylam Pharmaceuticals, Inc. | 24.90 |
| Anika Therapeutics, Inc. | 2.028 |
| Savara, Inc. | 7.199 |
| Vericel Corp. | 5.606 |
Price to Book Value Related Metrics
| Price | 1.025 |
| Market Cap | 13.42M |